This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Who influences consumers’ understanding of drug risks in TV ads?
Analyzing the impact of endorsers on TV prescription drug ads
Challenge
The Food and Drug Administration’s (FDA’s) regulations about prescription drug promotion ensure that claims are truthful, accurately communicated, and offer a balanced presentation of the product’s risks and benefits. Currently, however, they do not require disclosure of an endorser’s relationship to the drug.
Marketers use “everyday people” in prescription drug advertising, anticipating consumers will
- Identify with the individual endorsing the product
- Perceive the endorser as credible
- Ask doctors about the product being advertised
The FDA has tapped Westat to examine the effectiveness of using endorsers to market prescription drugs and their impact on consumers’ understanding of a prescription drug’s risks and benefits.
Solution
Working with FDA, Westat will field 2 experimental survey research studies with consumers using the selected medical conditions and analyze the results.
For this research, we are developing 2 sets of television ads for 2 different fictitious prescription drugs. For each set of ads, we will be manipulating important details, including a disclosure statement where we tell participants the spokesperson actually uses/prescribes the drug or is an actor, or we use a control where we say nothing. We are also analyzing the impact depending on whether the endorser is a patient or a physician.
We are ensuring that the creative products we develop for the study are realistic, believable, and conform to FDA guidance around direct-to-consumer (DTC) television promotion.
Our qualitative researchers will evaluate the study questionnaire and supporting materials to ensure they are working as expected with the target consumer audiences.
Results
Study results will contribute to the scientific evidence base around the effectiveness of using endorsers to promote prescription drugs to consumers. In so doing, Westat is helping FDA to ensure that prescription drug promotion is truthful, balanced, and accurately communicated.
Focus Areas
Health Communications Public HealthCapabilities
Communications Data Collection Statistical Methods-
Issue Brief
Young Children’s Consumption of 100% Fruit Juice by Racial-Ethnic Characteristics of Their MothersMarch 2023
Congress authorized the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) as a pilot program in 1972 and made WIC permanent in 1974.…
-
Perspective
CDISC Conformance and Compliance: So Many Resources, So Little Time!February 2023
Implementing the Clinical Data Interchange Standards Consortium (CDISC) standards required for data management, programming, documentation, and eCTD data submission can be challenging for many reasons…
-
Expert Interview
How Will the Marine Corps Integrate Men and Women at Recruit Training?January 2023
Marine Corps recruit training is every bit as intense as it looks. Each morning starts hours before sunrise with a chorus of screaming drill instructors…